NCT04700358View on ClinicalTrials.gov

Characterization of Antibacterial Antibodies in Patients With Cystic Fibrosis

RecruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

September 30, 2027

Study Completion Date

December 31, 2027

Conditions
Pulmonary Cystic FibrosisNeutralizing Antibodies
Interventions
OTHER

Blood sampling

"Screening: Blood sampling of 15 ml whole blood~B cell isolation: Blood sampling of max. 400 ml whole blood or 6% of the total blood volume (♀ 65 ∓ 10 ml/kg; ♂ 77 ∓ 10 ml/kg)"

Trial Locations (1)

Unknown

RECRUITING

CF Study Center, University Hospital Cologne, Cologne

All Listed Sponsors
lead

University Hospital of Cologne

OTHER